Eli Lilly's weight loss pill Foundayo wins backing from European regulators after trials show up to 11% body weight loss
Polymarket · x · 2026-10-16
Breaking news via Polymarket: Eli Lilly's oral weight loss drug Foundayo has won backing from European drug regulators, with clinical trials showing patients losing up to 11% of their body weight.
More from AGI Musings
- Mathematicians' AI-skeptic arguments keep beating the rebuttals, says Charton — f_charton · 2026-10-17
- Dean Ball: Hayek's spontaneous-order ideas are strikingly relevant to AI, yet his heirs peddle AI cope — deanwball · 2026-10-17
- Ex-xAI researcher: biggest AI question is innovation vs scaling, and scaling favors Big Tech — finbarrtimbers · 2026-10-17
- Investor Stewart Alsop: LLMs made him less worried about AI doomer scenarios — StewartalsopIII · 2026-10-17
- China doesn't need better AI—it needs to make American AI unprofitable, argues founder — r0ck3t23 · 2026-10-17
- Zvi: under time pressure, alignment solutions will always be last-minute vibe-coded — TheZvi · 2026-10-17